NeuroOne Medical Technologies Corporation Net Income (Loss) Available to Common Stockholders, Diluted
NeuroOne Medical Technologies Corporation (NMTC) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$2.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was -$2.41M.
- NeuroOne Medical Technologies Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was -$2.38M.
- NeuroOne Medical Technologies Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-06-30 was -$1.50M.
- NeuroOne Medical Technologies Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-03-31 was -$2.27M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.41M 10-Q · filed 2026-08-13 | -$4.79M derived: sum of 2 quarters · filed 2026-08-13 | -$6.44M 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$2.38M 10-Q/A · filed 2026-06-12 | -$2.09M 10-Q · filed 2026-05-12 | -$4.03M 10-Q/A · filed 2026-06-12 | -$3.74M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | -$1.50M 10-Q · filed 2026-08-13 | -$3.77M derived: sum of 2 quarters · filed 2026-08-13 | -$1.99M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$2.27M 10-Q/A · filed 2026-06-12 | -$485.29K 10-Q/A · filed 2026-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |